Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.
Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.
Senate approves NIH funding bill. NCI awards $25 million to eight institutions for patient navigator programs; $35 million awarded for nanotechnology partnerships.
NIH-funded HapMap consortium publishes first phase of catalog.
NIH begins transition to electronic grant submissions; seeks comment on options for NRSA funding.
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pam Bondi diagnosed with thyroid cancer









